Hereditary Angioedema Drug Market Report

Global Hereditary Angioedema Drug Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Sep 24, 2020
  • PAGES：140
  • REPORT CODE：GMM593543
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Hereditary Angioedema Drug is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.2% during the forecast period. The research provides insights for the global Hereditary Angioedema Drug market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Hereditary Angioedema Drug industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Hereditary Angioedema Drug Market Segmentations:

    By Players:

    • CSL Limited

    • Pharming Group NV

    • Shire plc

    • IBio Inc

    • Ionis Pharmaceuticals, Inc

    • BioCryst Pharmaceuticals, Inc

    By Types:

    • C1 Esterase Inhibitor

    • Kallikrein Inhibitor

    • Selective Bradykinin B2 Receptor Antagonist

    By End-User:

    • Retail Pharmacies

    • Hospital Pharmacies

    • Online Pharmacies

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Hereditary Angioedema Drug Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Hereditary Angioedema Drug Market Size and Growth Rate of C1 Esterase Inhibitor from 2014 to 2026

      • 1.3.2 Global Hereditary Angioedema Drug Market Size and Growth Rate of Kallikrein Inhibitor from 2014 to 2026

      • 1.3.3 Global Hereditary Angioedema Drug Market Size and Growth Rate of Selective Bradykinin B2 Receptor Antagonist from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Hereditary Angioedema Drug Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

      • 1.4.2 Global Hereditary Angioedema Drug Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

      • 1.4.3 Global Hereditary Angioedema Drug Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Hereditary Angioedema Drug Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Hereditary Angioedema Drug Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Hereditary Angioedema Drug by Major Types

      • 3.4.1 Hereditary Angioedema Drug Market Size and Growth Rate of C1 Esterase Inhibitor

      • 3.4.2 Hereditary Angioedema Drug Market Size and Growth Rate of Kallikrein Inhibitor

      • 3.4.3 Hereditary Angioedema Drug Market Size and Growth Rate of Selective Bradykinin B2 Receptor Antagonist

    4 Segmentation of Hereditary Angioedema Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Hereditary Angioedema Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Hereditary Angioedema Drug in Retail Pharmacies

      • 4.4.2 Market Size and Growth Rate of Hereditary Angioedema Drug in Hospital Pharmacies

      • 4.4.3 Market Size and Growth Rate of Hereditary Angioedema Drug in Online Pharmacies

    5 Market Analysis by Major Regions

    • 5.1 Global Hereditary Angioedema Drug Production Analysis by Major Regions

    • 5.2 Global Hereditary Angioedema Drug Consumption Analysis by Major Regions

    • 5.3 Global Hereditary Angioedema Drug Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Hereditary Angioedema Drug Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Hereditary Angioedema Drug Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Hereditary Angioedema Drug Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Hereditary Angioedema Drug Production, Import, Consumption and Export Analysis

    6 Product Commodity of Hereditary Angioedema Drug Market in Major Countries

    • 6.1 Top 5 Export Countries in Hereditary Angioedema Drug market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Hereditary Angioedema Drug market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Hereditary Angioedema Drug market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Hereditary Angioedema Drug market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Hereditary Angioedema Drug market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Hereditary Angioedema Drug market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Hereditary Angioedema Drug Landscape Analysis

    • 7.1 North America Hereditary Angioedema Drug Landscape Analysis by Major Types

    • 7.2 North America Hereditary Angioedema Drug Landscape Analysis by Major End-Users

    • 7.3 North America Hereditary Angioedema Drug Landscape Analysis by Major Countries

      • 7.3.1 United States Hereditary Angioedema Drug Market Volume and Growth Rate

      • 7.3.2 Canada Hereditary Angioedema Drug Market Volume and Growth Rate

      • 7.3.3 Mexico Hereditary Angioedema Drug Market Volume and Growth Rate

    8 Europe Hereditary Angioedema Drug Landscape Analysis

    • 8.1 Europe Hereditary Angioedema Drug Landscape Analysis by Major Types

    • 8.2 Europe Hereditary Angioedema Drug Landscape Analysis by Major End-Users

    • 8.3 Europe Hereditary Angioedema Drug Landscape Analysis by Major Countries

      • 8.3.1 Germany Hereditary Angioedema Drug Market Volume and Growth Rate

      • 8.3.2 UK Hereditary Angioedema Drug Market Volume and Growth Rate

      • 8.3.3 France Hereditary Angioedema Drug Market Volume and Growth Rate

      • 8.3.4 Italy Hereditary Angioedema Drug Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Hereditary Angioedema Drug Market Volume and Growth Rate

      • 8.3.6 Spain Hereditary Angioedema Drug Market Volume and Growth Rate

      • 8.3.7 Belgium Hereditary Angioedema Drug Market Volume and Growth Rate

      • 8.3.8 Poland Hereditary Angioedema Drug Market Volume and Growth Rate

      • 8.3.9 Russia Hereditary Angioedema Drug Market Volume and Growth Rate

      • 8.3.10 Turkey Hereditary Angioedema Drug Market Volume and Growth Rate

    9 Asia Pacific Hereditary Angioedema Drug Landscape Analysis

    • 9.1 Asia Pacific Hereditary Angioedema Drug Landscape Analysis by Major Types

    • 9.2 Asia Pacific Hereditary Angioedema Drug Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Hereditary Angioedema Drug Landscape Analysis by Major Countries

      • 9.3.1 China Hereditary Angioedema Drug Market Volume and Growth Rate

      • 9.3.2 Japan Hereditary Angioedema Drug Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Hereditary Angioedema Drug Market Volume and Growth Rate

      • 9.3.4 India Hereditary Angioedema Drug Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Hereditary Angioedema Drug Market Volume and Growth Rate

      • 9.3.6 South Korea Hereditary Angioedema Drug Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Hereditary Angioedema Drug Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Hereditary Angioedema Drug Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Hereditary Angioedema Drug Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Hereditary Angioedema Drug Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Hereditary Angioedema Drug Market Volume and Growth Rate

      • 10.3.2 Brazil Hereditary Angioedema Drug Market Volume and Growth Rate

      • 10.3.3 Nigeria Hereditary Angioedema Drug Market Volume and Growth Rate

      • 10.3.4 South Africa Hereditary Angioedema Drug Market Volume and Growth Rate 

      • 10.3.5 Argentina Hereditary Angioedema Drug Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 CSL Limited

      • 11.1.1 CSL Limited Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Pharming Group NV

      • 11.2.1 Pharming Group NV Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Shire plc

      • 11.3.1 Shire plc Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 IBio Inc

      • 11.4.1 IBio Inc Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Ionis Pharmaceuticals, Inc

      • 11.5.1 Ionis Pharmaceuticals, Inc Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 BioCryst Pharmaceuticals, Inc

      • 11.6.1 BioCryst Pharmaceuticals, Inc Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 110 Figures and 185 Tables)

    • Figure Product Picture

    • Figure Hereditary Angioedema Drug Market Size and Growth Rate of C1 Esterase Inhibitor from 2014 to 2026

    • Figure Hereditary Angioedema Drug Market Size and Growth Rate of Kallikrein Inhibitor from 2014 to 2026

    • Figure Hereditary Angioedema Drug Market Size and Growth Rate of Selective Bradykinin B2 Receptor Antagonist from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Hereditary Angioedema Drug Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Figure Global Hereditary Angioedema Drug Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • Figure Global Hereditary Angioedema Drug Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Hereditary Angioedema Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Hereditary Angioedema Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Hereditary Angioedema Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Hereditary Angioedema Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Hereditary Angioedema Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of C1 Esterase Inhibitor

    • Figure Market Size and Growth Rate of Kallikrein Inhibitor

    • Figure Market Size and Growth Rate of Selective Bradykinin B2 Receptor Antagonist

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Hereditary Angioedema Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Hereditary Angioedema Drug by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Figure Market Size and Growth Rate of Hospital Pharmacies

    • Figure Market Size and Growth Rate of Online Pharmacies

    • Table Global Hereditary Angioedema Drug Production by Major Regions

    • Table Global Hereditary Angioedema Drug Production Share by Major Regions

    • Figure Global Hereditary Angioedema Drug Production Share by Major Regions in 2014

    • Figure Global Hereditary Angioedema Drug Production Share by Major Regions in 2018

    • Figure Global Hereditary Angioedema Drug Production Share by Major Regions in 2026

    • Table Global Hereditary Angioedema Drug Consumption by Major Regions

    • Table Global Hereditary Angioedema Drug Consumption Share by Major Regions

    • Figure Global Hereditary Angioedema Drug Consumption Share by Major Regions in 2014

    • Figure Global Hereditary Angioedema Drug Consumption Share by Major Regions in 2018

    • Figure Global Hereditary Angioedema Drug Consumption Share by Major Regions in 2026

    • Table North America Hereditary Angioedema Drug Production, Import, Consumption and Export Analysis

    • Table Europe Hereditary Angioedema Drug Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Hereditary Angioedema Drug Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Hereditary Angioedema Drug Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Hereditary Angioedema Drug market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Hereditary Angioedema Drug market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Hereditary Angioedema Drug market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Hereditary Angioedema Drug market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Hereditary Angioedema Drug Consumption by Types from 2014 to 2026

    • Table North America Hereditary Angioedema Drug Consumption Share by Types from 2014 to 2026

    • Figure North America Hereditary Angioedema Drug Consumption Share by Types in 2014

    • Figure North America Hereditary Angioedema Drug Consumption Share by Types in 2018

    • Figure North America Hereditary Angioedema Drug Consumption Share by Types in 2026

    • Table North America Hereditary Angioedema Drug Consumption by End-Users from 2014 to 2026

    • Table North America Hereditary Angioedema Drug Consumption Share by End-Users from 2014 to 2026

    • Figure North America Hereditary Angioedema Drug Consumption Share by End-Users in 2014

    • Figure North America Hereditary Angioedema Drug Consumption Share by End-Users in 2018

    • Figure North America Hereditary Angioedema Drug Consumption Share by End-Users in 2026

    • Table North America Hereditary Angioedema Drug Consumption by Major Countries from 2014 to 2026

    • Table North America Hereditary Angioedema Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Hereditary Angioedema Drug Consumption Share by Major Countries in 2014

    • Figure North America Hereditary Angioedema Drug Consumption Share by Major Countries in 2018

    • Figure North America Hereditary Angioedema Drug Consumption Share by Major Countries in 2026

    • Figure United States Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Hereditary Angioedema Drug Consumption by Types from 2014 to 2026

    • Table Europe Hereditary Angioedema Drug Consumption Share by Types from 2014 to 2026

    • Figure Europe Hereditary Angioedema Drug Consumption Share by Types in 2014

    • Figure Europe Hereditary Angioedema Drug Consumption Share by Types in 2018

    • Figure Europe Hereditary Angioedema Drug Consumption Share by Types in 2026

    • Table Europe Hereditary Angioedema Drug Consumption by End-Users from 2014 to 2026

    • Table Europe Hereditary Angioedema Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Hereditary Angioedema Drug Consumption Share by End-Users in 2014

    • Figure Europe Hereditary Angioedema Drug Consumption Share by End-Users in 2018

    • Figure Europe Hereditary Angioedema Drug Consumption Share by End-Users in 2026

    • Table Europe Hereditary Angioedema Drug Consumption by Major Countries from 2014 to 2026

    • Table Europe Hereditary Angioedema Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Hereditary Angioedema Drug Consumption Share by Major Countries in 2014

    • Figure Europe Hereditary Angioedema Drug Consumption Share by Major Countries in 2018

    • Figure Europe Hereditary Angioedema Drug Consumption Share by Major Countries in 2026

    • Figure Germany Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure France Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Hereditary Angioedema Drug Consumption by Types from 2014 to 2026

    • Table Asia Pacific Hereditary Angioedema Drug Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Hereditary Angioedema Drug Consumption Share by Types in 2014

    • Figure Asia Pacific Hereditary Angioedema Drug Consumption Share by Types in 2018

    • Figure Asia Pacific Hereditary Angioedema Drug Consumption Share by Types in 2026

    • Table Asia Pacific Hereditary Angioedema Drug Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Hereditary Angioedema Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Hereditary Angioedema Drug Consumption Share by End-Users in 2014

    • Figure Asia Pacific Hereditary Angioedema Drug Consumption Share by End-Users in 2018

    • Figure Asia Pacific Hereditary Angioedema Drug Consumption Share by End-Users in 2026

    • Table Asia Pacific Hereditary Angioedema Drug Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Hereditary Angioedema Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Hereditary Angioedema Drug Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Hereditary Angioedema Drug Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Hereditary Angioedema Drug Consumption Share by Major Countries in 2026

    • Figure China Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandHereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure India Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Hereditary Angioedema Drug Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Hereditary Angioedema Drug Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Drug Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Drug Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Drug Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Hereditary Angioedema Drug Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Hereditary Angioedema Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Drug Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Drug Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Drug Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Hereditary Angioedema Drug Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Hereditary Angioedema Drug Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Drug Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Drug Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Hereditary Angioedema Drug Consumption Share by Major Countries in 2026

    • Figure GCC Countries Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Hereditary Angioedema Drug Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of CSL Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Limited

    • Figure Sales and Growth Rate Analysis of CSL Limited

    • Figure Revenue and Market Share Analysis of CSL Limited

    • Table Product and Service Introduction of CSL Limited

    • Table Company Profile and Development Status of Pharming Group NV

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharming Group NV

    • Figure Sales and Growth Rate Analysis of Pharming Group NV

    • Figure Revenue and Market Share Analysis of Pharming Group NV

    • Table Product and Service Introduction of Pharming Group NV

    • Table Company Profile and Development Status of Shire plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire plc

    • Figure Sales and Growth Rate Analysis of Shire plc

    • Figure Revenue and Market Share Analysis of Shire plc

    • Table Product and Service Introduction of Shire plc

    • Table Company Profile and Development Status of IBio Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of IBio Inc

    • Figure Sales and Growth Rate Analysis of IBio Inc

    • Figure Revenue and Market Share Analysis of IBio Inc

    • Table Product and Service Introduction of IBio Inc

    • Table Company Profile and Development Status of Ionis Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ionis Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of Ionis Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of Ionis Pharmaceuticals, Inc

    • Table Product and Service Introduction of Ionis Pharmaceuticals, Inc

    • Table Company Profile and Development Status of BioCryst Pharmaceuticals, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioCryst Pharmaceuticals, Inc

    • Figure Sales and Growth Rate Analysis of BioCryst Pharmaceuticals, Inc

    • Figure Revenue and Market Share Analysis of BioCryst Pharmaceuticals, Inc

    • Table Product and Service Introduction of BioCryst Pharmaceuticals, Inc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US